<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04953039</url>
  </required_header>
  <id_info>
    <org_study_id>SALIVA-01</org_study_id>
    <nct_id>NCT04953039</nct_id>
  </id_info>
  <brief_title>Use of Saliva for COVID-19 Diagnosis</brief_title>
  <acronym>SALIVA-01</acronym>
  <official_title>Use of Saliva for Diagnosis of SARS-CoV2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milano Bicocca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with&#xD;
      suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for&#xD;
      the diagnosis of SARS-CoV2 infections.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 19, 2020</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Actual">October 12, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Presence of SARS-CoV2 RNA in the saliva of patient with suspected or confirmed COVID-19.</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Positive - Negative</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>SARS-CoV2 Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected or confirmed SARS-CoV2 infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients â‰¥ 18 years of age hospitalized in the COVID-19 wards of ASST Monza - San&#xD;
             Gerardo Hospital with positive, weakly positive or negative nasopharyngeal swabs;&#xD;
             initially assessed at the E.R.; symptomatic or asymptomatic with indication to&#xD;
             hospitalization.&#xD;
&#xD;
          -  Informed consent freely granted and acquired before the start of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with significant clinical conditions which could interfere with the study in&#xD;
             the opinion of the researchers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giorgio Novelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ASST Monza - Ospedale San Gerardo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ASST MONZA - Ospedale San Gerardo</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>October 16, 2021</last_update_submitted>
  <last_update_submitted_qc>October 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milano Bicocca</investigator_affiliation>
    <investigator_full_name>Giorgio Novelli</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Salivary test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

